Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.936 |
High Similarity |
NPD4625 |
Phase 3 |
0.9187 |
High Similarity |
NPD4749 |
Approved |
0.8871 |
High Similarity |
NPD1610 |
Phase 2 |
0.8852 |
High Similarity |
NPD1548 |
Phase 1 |
0.8828 |
High Similarity |
NPD4908 |
Phase 1 |
0.8692 |
High Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.8692 |
High Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.8538 |
High Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.8462 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.8382 |
Intermediate Similarity |
NPD6100 |
Approved |
0.8382 |
Intermediate Similarity |
NPD6099 |
Approved |
0.8321 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.8284 |
Intermediate Similarity |
NPD1613 |
Approved |
0.8284 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.8281 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.816 |
Intermediate Similarity |
NPD6671 |
Approved |
0.8115 |
Intermediate Similarity |
NPD4750 |
Phase 3 |
0.8106 |
Intermediate Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.806 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.8014 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7955 |
Intermediate Similarity |
NPD6696 |
Suspended |
0.7887 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7868 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7833 |
Intermediate Similarity |
NPD940 |
Approved |
0.7833 |
Intermediate Similarity |
NPD846 |
Approved |
0.7817 |
Intermediate Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.7793 |
Intermediate Similarity |
NPD7447 |
Phase 1 |
0.7793 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7761 |
Intermediate Similarity |
NPD2797 |
Approved |
0.775 |
Intermediate Similarity |
NPD1242 |
Phase 1 |
0.7744 |
Intermediate Similarity |
NPD3600 |
Clinical (unspecified phase) |
0.7724 |
Intermediate Similarity |
NPD7212 |
Phase 2 |
0.7724 |
Intermediate Similarity |
NPD7213 |
Phase 3 |
0.7704 |
Intermediate Similarity |
NPD6584 |
Phase 3 |
0.7698 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7698 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7671 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7647 |
Intermediate Similarity |
NPD3018 |
Phase 2 |
0.7643 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7626 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7606 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7603 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7578 |
Intermediate Similarity |
NPD1398 |
Phase 1 |
0.7576 |
Intermediate Similarity |
NPD4626 |
Approved |
0.7552 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7552 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7551 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7538 |
Intermediate Similarity |
NPD7340 |
Approved |
0.7537 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7536 |
Intermediate Similarity |
NPD7095 |
Approved |
0.7535 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7535 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7521 |
Intermediate Similarity |
NPD3020 |
Approved |
0.7518 |
Intermediate Similarity |
NPD4097 |
Suspended |
0.7517 |
Intermediate Similarity |
NPD7466 |
Approved |
0.7517 |
Intermediate Similarity |
NPD3892 |
Phase 2 |
0.75 |
Intermediate Similarity |
NPD1240 |
Approved |
0.75 |
Intermediate Similarity |
NPD1512 |
Approved |
0.75 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.75 |
Intermediate Similarity |
NPD2801 |
Approved |
0.75 |
Intermediate Similarity |
NPD5535 |
Approved |
0.75 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7482 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7481 |
Intermediate Similarity |
NPD6583 |
Phase 3 |
0.7481 |
Intermediate Similarity |
NPD6582 |
Phase 2 |
0.7481 |
Intermediate Similarity |
NPD2982 |
Phase 2 |
0.7481 |
Intermediate Similarity |
NPD2983 |
Phase 2 |
0.7463 |
Intermediate Similarity |
NPD1611 |
Approved |
0.746 |
Intermediate Similarity |
NPD2684 |
Approved |
0.7444 |
Intermediate Similarity |
NPD1778 |
Approved |
0.7442 |
Intermediate Similarity |
NPD5283 |
Phase 1 |
0.744 |
Intermediate Similarity |
NPD968 |
Approved |
0.7436 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7434 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7426 |
Intermediate Similarity |
NPD8651 |
Approved |
0.7426 |
Intermediate Similarity |
NPD3225 |
Approved |
0.7417 |
Intermediate Similarity |
NPD2859 |
Approved |
0.7417 |
Intermediate Similarity |
NPD844 |
Approved |
0.7417 |
Intermediate Similarity |
NPD2860 |
Approved |
0.7413 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7413 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.7407 |
Intermediate Similarity |
NPD2981 |
Phase 2 |
0.7403 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7386 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7381 |
Intermediate Similarity |
NPD2342 |
Discontinued |
0.7379 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7376 |
Intermediate Similarity |
NPD2238 |
Phase 2 |
0.7368 |
Intermediate Similarity |
NPD1651 |
Approved |
0.7368 |
Intermediate Similarity |
NPD5691 |
Approved |
0.7365 |
Intermediate Similarity |
NPD7837 |
Clinical (unspecified phase) |
0.7364 |
Intermediate Similarity |
NPD7635 |
Approved |
0.7361 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7355 |
Intermediate Similarity |
NPD288 |
Approved |
0.7353 |
Intermediate Similarity |
NPD5327 |
Phase 3 |
0.7338 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7333 |
Intermediate Similarity |
NPD2934 |
Approved |
0.7333 |
Intermediate Similarity |
NPD2933 |
Approved |
0.7328 |
Intermediate Similarity |
NPD7157 |
Approved |
0.7328 |
Intermediate Similarity |
NPD709 |
Approved |
0.7324 |
Intermediate Similarity |
NPD5735 |
Approved |
0.7319 |
Intermediate Similarity |
NPD4624 |
Approved |
0.7313 |
Intermediate Similarity |
NPD17 |
Approved |
0.7299 |
Intermediate Similarity |
NPD1283 |
Approved |
0.7297 |
Intermediate Similarity |
NPD6815 |
Approved |
0.7287 |
Intermediate Similarity |
NPD228 |
Approved |
0.7279 |
Intermediate Similarity |
NPD2232 |
Approved |
0.7279 |
Intermediate Similarity |
NPD2233 |
Approved |
0.7279 |
Intermediate Similarity |
NPD2230 |
Approved |
0.7278 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7273 |
Intermediate Similarity |
NPD6353 |
Approved |
0.7267 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7266 |
Intermediate Similarity |
NPD3022 |
Approved |
0.7266 |
Intermediate Similarity |
NPD3021 |
Approved |
0.7266 |
Intermediate Similarity |
NPD5451 |
Approved |
0.7254 |
Intermediate Similarity |
NPD1558 |
Phase 1 |
0.7254 |
Intermediate Similarity |
NPD4140 |
Approved |
0.7244 |
Intermediate Similarity |
NPD290 |
Approved |
0.7244 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7234 |
Intermediate Similarity |
NPD6812 |
Clinical (unspecified phase) |
0.7231 |
Intermediate Similarity |
NPD7843 |
Approved |
0.7214 |
Intermediate Similarity |
NPD1008 |
Clinical (unspecified phase) |
0.7211 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7206 |
Intermediate Similarity |
NPD1091 |
Approved |
0.719 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.719 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7185 |
Intermediate Similarity |
NPD2668 |
Approved |
0.7185 |
Intermediate Similarity |
NPD6516 |
Phase 2 |
0.7185 |
Intermediate Similarity |
NPD2667 |
Approved |
0.7185 |
Intermediate Similarity |
NPD5846 |
Approved |
0.7179 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7179 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7171 |
Intermediate Similarity |
NPD1653 |
Approved |
0.717 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7162 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7152 |
Intermediate Similarity |
NPD6746 |
Phase 2 |
0.7143 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7143 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7143 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD7037 |
Approved |
0.7134 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7134 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7134 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7133 |
Intermediate Similarity |
NPD4307 |
Phase 2 |
0.7133 |
Intermediate Similarity |
NPD5837 |
Clinical (unspecified phase) |
0.7132 |
Intermediate Similarity |
NPD3496 |
Discontinued |
0.7123 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7122 |
Intermediate Similarity |
NPD3267 |
Approved |
0.7122 |
Intermediate Similarity |
NPD3266 |
Approved |
0.7115 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7113 |
Intermediate Similarity |
NPD1296 |
Phase 2 |
0.7113 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7111 |
Intermediate Similarity |
NPD3445 |
Approved |
0.7111 |
Intermediate Similarity |
NPD3443 |
Approved |
0.7111 |
Intermediate Similarity |
NPD3444 |
Approved |
0.7107 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7103 |
Intermediate Similarity |
NPD4536 |
Approved |
0.7103 |
Intermediate Similarity |
NPD4537 |
Clinical (unspecified phase) |
0.7103 |
Intermediate Similarity |
NPD4538 |
Approved |
0.7103 |
Intermediate Similarity |
NPD2200 |
Suspended |
0.7101 |
Intermediate Similarity |
NPD1669 |
Approved |
0.7099 |
Intermediate Similarity |
NPD821 |
Approved |
0.7097 |
Intermediate Similarity |
NPD37 |
Approved |
0.7095 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7095 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.7089 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7086 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7086 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7086 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7083 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7081 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7081 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7081 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7081 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.708 |
Intermediate Similarity |
NPD1281 |
Approved |
0.7075 |
Intermediate Similarity |
NPD5763 |
Approved |
0.7075 |
Intermediate Similarity |
NPD5762 |
Approved |
0.7075 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7075 |
Intermediate Similarity |
NPD3540 |
Phase 1 |
0.7071 |
Intermediate Similarity |
NPD3691 |
Phase 2 |
0.7071 |
Intermediate Similarity |
NPD3690 |
Phase 2 |
0.707 |
Intermediate Similarity |
NPD4965 |
Approved |
0.707 |
Intermediate Similarity |
NPD4966 |
Approved |
0.707 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7068 |
Intermediate Similarity |
NPD2557 |
Approved |
0.7067 |
Intermediate Similarity |
NPD6667 |
Approved |
0.7067 |
Intermediate Similarity |
NPD6666 |
Approved |
0.7051 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7051 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7051 |
Intermediate Similarity |
NPD5929 |
Approved |
0.7049 |
Intermediate Similarity |
NPD1432 |
Clinical (unspecified phase) |
0.704 |
Intermediate Similarity |
NPD289 |
Clinical (unspecified phase) |
0.7039 |
Intermediate Similarity |
NPD1940 |
Clinical (unspecified phase) |
0.7039 |
Intermediate Similarity |
NPD5261 |
Clinical (unspecified phase) |
0.7037 |
Intermediate Similarity |
NPD6581 |
Approved |
0.7037 |
Intermediate Similarity |
NPD6580 |
Approved |
0.7032 |
Intermediate Similarity |
NPD6072 |
Discontinued |
0.7029 |
Intermediate Similarity |
NPD2235 |
Phase 2 |
0.7029 |
Intermediate Similarity |
NPD2231 |
Phase 2 |
0.702 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7019
|
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |